nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—systemic scleroderma—rheumatoid arthritis	0.28	0.551	CtDrD
Leflunomide—AHR—rheumatoid arthritis	0.275	1	CbGaD
Leflunomide—systemic lupus erythematosus—rheumatoid arthritis	0.228	0.449	CtDrD
Leflunomide—ABCG2—Sulfasalazine—rheumatoid arthritis	0.0255	0.255	CbGbCtD
Leflunomide—ABCG2—Hydrocortisone—rheumatoid arthritis	0.0204	0.204	CbGbCtD
Leflunomide—ABCG2—Cyclosporine—rheumatoid arthritis	0.0193	0.193	CbGbCtD
Leflunomide—ABCG2—Dexamethasone—rheumatoid arthritis	0.0127	0.127	CbGbCtD
Leflunomide—ABCG2—Methotrexate—rheumatoid arthritis	0.0102	0.102	CbGbCtD
Leflunomide—CYP2C9—Cyclosporine—rheumatoid arthritis	0.00717	0.0717	CbGbCtD
Leflunomide—CYP2C9—Dexamethasone—rheumatoid arthritis	0.00472	0.0472	CbGbCtD
Leflunomide—DHODH—lymphoid tissue—rheumatoid arthritis	0.000354	0.121	CbGeAlD
Leflunomide—DHODH—tendon—rheumatoid arthritis	0.000333	0.114	CbGeAlD
Leflunomide—PTK2B—connective tissue—rheumatoid arthritis	0.000307	0.105	CbGeAlD
Leflunomide—AHR—parotid gland—rheumatoid arthritis	0.000287	0.0982	CbGeAlD
Leflunomide—AHR—saliva-secreting gland—rheumatoid arthritis	0.000275	0.0941	CbGeAlD
Leflunomide—PTK2B—lymphoid tissue—rheumatoid arthritis	0.000224	0.0769	CbGeAlD
Leflunomide—PTK2B—digestive system—rheumatoid arthritis	0.000222	0.076	CbGeAlD
Leflunomide—PTK2B—tendon—rheumatoid arthritis	0.000211	0.0723	CbGeAlD
Leflunomide—AHR—digestive system—rheumatoid arthritis	0.000182	0.0624	CbGeAlD
Leflunomide—AHR—tendon—rheumatoid arthritis	0.000173	0.0594	CbGeAlD
Leflunomide—Niflumic Acid—PTGS2—rheumatoid arthritis	0.000147	1	CrCbGaD
Leflunomide—ABCG2—parotid gland—rheumatoid arthritis	0.000111	0.0381	CbGeAlD
Leflunomide—ABCG2—saliva-secreting gland—rheumatoid arthritis	0.000107	0.0365	CbGeAlD
Leflunomide—CYP1A2—digestive system—rheumatoid arthritis	6.8e-05	0.0233	CbGeAlD
Leflunomide—CYP2C9—digestive system—rheumatoid arthritis	6.46e-05	0.0221	CbGeAlD
Leflunomide—ABCG2—Fluoropyrimidine Activity—TP53—rheumatoid arthritis	3.78e-05	0.000966	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—NFKB1—rheumatoid arthritis	3.65e-05	0.000932	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—MAPK8—rheumatoid arthritis	3.59e-05	0.000917	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HLA-DRB1—rheumatoid arthritis	3.53e-05	0.000901	CbGpPWpGaD
Leflunomide—Paraesthesia—Hydrocortisone—rheumatoid arthritis	3.5e-05	0.000465	CcSEcCtD
Leflunomide—AHR—Circadian rythm related genes—TP53—rheumatoid arthritis	3.49e-05	0.000892	CbGpPWpGaD
Leflunomide—Urticaria—Cyclosporine—rheumatoid arthritis	3.48e-05	0.000463	CcSEcCtD
Leflunomide—Myalgia—Dexamethasone—rheumatoid arthritis	3.47e-05	0.000462	CcSEcCtD
Leflunomide—Myalgia—Betamethasone—rheumatoid arthritis	3.47e-05	0.000462	CcSEcCtD
Leflunomide—Abdominal pain—Cyclosporine—rheumatoid arthritis	3.47e-05	0.000461	CcSEcCtD
Leflunomide—Body temperature increased—Cyclosporine—rheumatoid arthritis	3.47e-05	0.000461	CcSEcCtD
Leflunomide—Anxiety—Betamethasone—rheumatoid arthritis	3.46e-05	0.00046	CcSEcCtD
Leflunomide—Anxiety—Dexamethasone—rheumatoid arthritis	3.46e-05	0.00046	CcSEcCtD
Leflunomide—Discomfort—Dexamethasone—rheumatoid arthritis	3.43e-05	0.000456	CcSEcCtD
Leflunomide—Discomfort—Betamethasone—rheumatoid arthritis	3.43e-05	0.000456	CcSEcCtD
Leflunomide—Dyspepsia—Hydrocortisone—rheumatoid arthritis	3.43e-05	0.000456	CcSEcCtD
Leflunomide—Haemoglobin—Methotrexate—rheumatoid arthritis	3.43e-05	0.000456	CcSEcCtD
Leflunomide—Hypotension—Methylprednisolone—rheumatoid arthritis	3.42e-05	0.000455	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—CXCL6—rheumatoid arthritis	3.42e-05	0.000874	CbGpPWpGaD
Leflunomide—Pain—Prednisolone—rheumatoid arthritis	3.41e-05	0.000454	CcSEcCtD
Leflunomide—Haemorrhage—Methotrexate—rheumatoid arthritis	3.41e-05	0.000453	CcSEcCtD
Leflunomide—Hepatitis—Methotrexate—rheumatoid arthritis	3.41e-05	0.000453	CcSEcCtD
Leflunomide—PTK2B—Immune System—ZAP70—rheumatoid arthritis	3.41e-05	0.000871	CbGpPWpGaD
Leflunomide—Decreased appetite—Hydrocortisone—rheumatoid arthritis	3.39e-05	0.00045	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—ICAM1—rheumatoid arthritis	3.39e-05	0.000865	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL6ST—rheumatoid arthritis	3.39e-05	0.000865	CbGpPWpGaD
Leflunomide—Pharyngitis—Methotrexate—rheumatoid arthritis	3.38e-05	0.00045	CcSEcCtD
Leflunomide—DHODH—Metabolism—CAT—rheumatoid arthritis	3.37e-05	0.00086	CbGpPWpGaD
Leflunomide—Urinary tract disorder—Methotrexate—rheumatoid arthritis	3.37e-05	0.000448	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	3.36e-05	0.000447	CcSEcCtD
Leflunomide—Fatigue—Hydrocortisone—rheumatoid arthritis	3.36e-05	0.000447	CcSEcCtD
Leflunomide—Vision blurred—Prednisone—rheumatoid arthritis	3.35e-05	0.000445	CcSEcCtD
Leflunomide—Urethral disorder—Methotrexate—rheumatoid arthritis	3.34e-05	0.000445	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	3.34e-05	0.000444	CcSEcCtD
Leflunomide—PTK2B—TCR Signaling Pathway—IL6—rheumatoid arthritis	3.34e-05	0.000852	CbGpPWpGaD
Leflunomide—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	3.34e-05	0.000443	CcSEcCtD
Leflunomide—Pain—Hydrocortisone—rheumatoid arthritis	3.33e-05	0.000443	CcSEcCtD
Leflunomide—Anaphylactic shock—Betamethasone—rheumatoid arthritis	3.33e-05	0.000443	CcSEcCtD
Leflunomide—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	3.33e-05	0.000443	CcSEcCtD
Leflunomide—Insomnia—Triamcinolone—rheumatoid arthritis	3.32e-05	0.000441	CcSEcCtD
Leflunomide—Insomnia—Methylprednisolone—rheumatoid arthritis	3.31e-05	0.00044	CcSEcCtD
Leflunomide—Infection—Betamethasone—rheumatoid arthritis	3.31e-05	0.00044	CcSEcCtD
Leflunomide—Infection—Dexamethasone—rheumatoid arthritis	3.31e-05	0.00044	CcSEcCtD
Leflunomide—Ill-defined disorder—Prednisone—rheumatoid arthritis	3.3e-05	0.000438	CcSEcCtD
Leflunomide—Paraesthesia—Triamcinolone—rheumatoid arthritis	3.29e-05	0.000438	CcSEcCtD
Leflunomide—Feeling abnormal—Prednisolone—rheumatoid arthritis	3.29e-05	0.000437	CcSEcCtD
Leflunomide—Paraesthesia—Methylprednisolone—rheumatoid arthritis	3.29e-05	0.000437	CcSEcCtD
Leflunomide—Anaemia—Prednisone—rheumatoid arthritis	3.28e-05	0.000437	CcSEcCtD
Leflunomide—Dyspnoea—Triamcinolone—rheumatoid arthritis	3.27e-05	0.000435	CcSEcCtD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—MAPK8—rheumatoid arthritis	3.27e-05	0.000834	CbGpPWpGaD
Leflunomide—Nervous system disorder—Dexamethasone—rheumatoid arthritis	3.26e-05	0.000434	CcSEcCtD
Leflunomide—Nervous system disorder—Betamethasone—rheumatoid arthritis	3.26e-05	0.000434	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—SYVN1—rheumatoid arthritis	3.26e-05	0.000833	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCL21—rheumatoid arthritis	3.26e-05	0.000833	CbGpPWpGaD
Leflunomide—Thrombocytopenia—Betamethasone—rheumatoid arthritis	3.26e-05	0.000433	CcSEcCtD
Leflunomide—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	3.26e-05	0.000433	CcSEcCtD
Leflunomide—Tachycardia—Dexamethasone—rheumatoid arthritis	3.25e-05	0.000432	CcSEcCtD
Leflunomide—Tachycardia—Betamethasone—rheumatoid arthritis	3.25e-05	0.000432	CcSEcCtD
Leflunomide—Angioedema—Prednisone—rheumatoid arthritis	3.25e-05	0.000432	CcSEcCtD
Leflunomide—Hypersensitivity—Cyclosporine—rheumatoid arthritis	3.23e-05	0.00043	CcSEcCtD
Leflunomide—Dyspepsia—Triamcinolone—rheumatoid arthritis	3.23e-05	0.000429	CcSEcCtD
Leflunomide—Erythema multiforme—Methotrexate—rheumatoid arthritis	3.22e-05	0.000429	CcSEcCtD
Leflunomide—Dyspepsia—Methylprednisolone—rheumatoid arthritis	3.22e-05	0.000428	CcSEcCtD
Leflunomide—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	3.22e-05	0.000428	CcSEcCtD
Leflunomide—Hyperhidrosis—Betamethasone—rheumatoid arthritis	3.22e-05	0.000428	CcSEcCtD
Leflunomide—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	3.21e-05	0.000427	CcSEcCtD
Leflunomide—Malaise—Prednisone—rheumatoid arthritis	3.2e-05	0.000426	CcSEcCtD
Leflunomide—AHR—Circadian rythm related genes—IL6—rheumatoid arthritis	3.2e-05	0.000817	CbGpPWpGaD
Leflunomide—Vertigo—Prednisone—rheumatoid arthritis	3.19e-05	0.000424	CcSEcCtD
Leflunomide—Eye disorder—Methotrexate—rheumatoid arthritis	3.19e-05	0.000424	CcSEcCtD
Leflunomide—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	3.19e-05	0.000424	CcSEcCtD
Leflunomide—Anorexia—Betamethasone—rheumatoid arthritis	3.17e-05	0.000422	CcSEcCtD
Leflunomide—Anorexia—Dexamethasone—rheumatoid arthritis	3.17e-05	0.000422	CcSEcCtD
Leflunomide—Urticaria—Prednisolone—rheumatoid arthritis	3.17e-05	0.000421	CcSEcCtD
Leflunomide—Cardiac disorder—Methotrexate—rheumatoid arthritis	3.16e-05	0.000421	CcSEcCtD
Leflunomide—Fatigue—Triamcinolone—rheumatoid arthritis	3.16e-05	0.000421	CcSEcCtD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	3.16e-05	0.000806	CbGpPWpGaD
Leflunomide—Fatigue—Methylprednisolone—rheumatoid arthritis	3.16e-05	0.00042	CcSEcCtD
Leflunomide—Asthenia—Cyclosporine—rheumatoid arthritis	3.15e-05	0.000418	CcSEcCtD
Leflunomide—Pain—Triamcinolone—rheumatoid arthritis	3.14e-05	0.000417	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—TAGAP—rheumatoid arthritis	3.13e-05	0.000799	CbGpPWpGaD
Leflunomide—Hypotension—Dexamethasone—rheumatoid arthritis	3.11e-05	0.000414	CcSEcCtD
Leflunomide—Hypotension—Betamethasone—rheumatoid arthritis	3.11e-05	0.000414	CcSEcCtD
Leflunomide—Pruritus—Cyclosporine—rheumatoid arthritis	3.1e-05	0.000412	CcSEcCtD
Leflunomide—Urticaria—Hydrocortisone—rheumatoid arthritis	3.1e-05	0.000412	CcSEcCtD
Leflunomide—Immune system disorder—Methotrexate—rheumatoid arthritis	3.08e-05	0.00041	CcSEcCtD
Leflunomide—Body temperature increased—Hydrocortisone—rheumatoid arthritis	3.08e-05	0.00041	CcSEcCtD
Leflunomide—Abdominal pain—Hydrocortisone—rheumatoid arthritis	3.08e-05	0.00041	CcSEcCtD
Leflunomide—Mediastinal disorder—Methotrexate—rheumatoid arthritis	3.07e-05	0.000409	CcSEcCtD
Leflunomide—Hypertension—Prednisone—rheumatoid arthritis	3.07e-05	0.000408	CcSEcCtD
Leflunomide—Chills—Methotrexate—rheumatoid arthritis	3.06e-05	0.000407	CcSEcCtD
Leflunomide—PTK2B—Immune System—FCGR3A—rheumatoid arthritis	3.04e-05	0.000776	CbGpPWpGaD
Leflunomide—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	3.03e-05	0.000403	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	3.03e-05	0.000403	CcSEcCtD
Leflunomide—Arthralgia—Prednisone—rheumatoid arthritis	3.02e-05	0.000402	CcSEcCtD
Leflunomide—Myalgia—Prednisone—rheumatoid arthritis	3.02e-05	0.000402	CcSEcCtD
Leflunomide—Feeling abnormal—Triamcinolone—rheumatoid arthritis	3.02e-05	0.000402	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL6R—rheumatoid arthritis	3.02e-05	0.000772	CbGpPWpGaD
Leflunomide—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	3.02e-05	0.000401	CcSEcCtD
Leflunomide—Anxiety—Prednisone—rheumatoid arthritis	3.01e-05	0.000401	CcSEcCtD
Leflunomide—Alopecia—Methotrexate—rheumatoid arthritis	3.01e-05	0.000401	CcSEcCtD
Leflunomide—Insomnia—Betamethasone—rheumatoid arthritis	3.01e-05	0.0004	CcSEcCtD
Leflunomide—Insomnia—Dexamethasone—rheumatoid arthritis	3.01e-05	0.0004	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	3e-05	0.000399	CcSEcCtD
Leflunomide—Diarrhoea—Cyclosporine—rheumatoid arthritis	3e-05	0.000399	CcSEcCtD
Leflunomide—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	2.99e-05	0.000398	CcSEcCtD
Leflunomide—Paraesthesia—Dexamethasone—rheumatoid arthritis	2.99e-05	0.000397	CcSEcCtD
Leflunomide—Paraesthesia—Betamethasone—rheumatoid arthritis	2.99e-05	0.000397	CcSEcCtD
Leflunomide—Discomfort—Prednisone—rheumatoid arthritis	2.99e-05	0.000397	CcSEcCtD
Leflunomide—Mental disorder—Methotrexate—rheumatoid arthritis	2.99e-05	0.000397	CcSEcCtD
Leflunomide—Malnutrition—Methotrexate—rheumatoid arthritis	2.97e-05	0.000395	CcSEcCtD
Leflunomide—Hypersensitivity—Prednisolone—rheumatoid arthritis	2.94e-05	0.000391	CcSEcCtD
Leflunomide—Dyspepsia—Betamethasone—rheumatoid arthritis	2.93e-05	0.00039	CcSEcCtD
Leflunomide—Dyspepsia—Dexamethasone—rheumatoid arthritis	2.93e-05	0.00039	CcSEcCtD
Leflunomide—Urticaria—Triamcinolone—rheumatoid arthritis	2.91e-05	0.000388	CcSEcCtD
Leflunomide—Urticaria—Methylprednisolone—rheumatoid arthritis	2.91e-05	0.000387	CcSEcCtD
Leflunomide—Dysgeusia—Methotrexate—rheumatoid arthritis	2.91e-05	0.000387	CcSEcCtD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—IL6—rheumatoid arthritis	2.91e-05	0.000742	CbGpPWpGaD
Leflunomide—Body temperature increased—Triamcinolone—rheumatoid arthritis	2.9e-05	0.000386	CcSEcCtD
Leflunomide—Dizziness—Cyclosporine—rheumatoid arthritis	2.9e-05	0.000386	CcSEcCtD
Leflunomide—Anaphylactic shock—Prednisone—rheumatoid arthritis	2.9e-05	0.000386	CcSEcCtD
Leflunomide—Abdominal pain—Methylprednisolone—rheumatoid arthritis	2.89e-05	0.000385	CcSEcCtD
Leflunomide—Decreased appetite—Dexamethasone—rheumatoid arthritis	2.89e-05	0.000385	CcSEcCtD
Leflunomide—Decreased appetite—Betamethasone—rheumatoid arthritis	2.89e-05	0.000385	CcSEcCtD
Leflunomide—PTK2B—Signaling by Interleukins—IL6—rheumatoid arthritis	2.88e-05	0.000737	CbGpPWpGaD
Leflunomide—Infection—Prednisone—rheumatoid arthritis	2.88e-05	0.000383	CcSEcCtD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—VEGFA—rheumatoid arthritis	2.87e-05	0.000734	CbGpPWpGaD
Leflunomide—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	2.87e-05	0.000382	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	2.87e-05	0.000382	CcSEcCtD
Leflunomide—Back pain—Methotrexate—rheumatoid arthritis	2.87e-05	0.000382	CcSEcCtD
Leflunomide—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	2.87e-05	0.000382	CcSEcCtD
Leflunomide—Fatigue—Dexamethasone—rheumatoid arthritis	2.87e-05	0.000382	CcSEcCtD
Leflunomide—Fatigue—Betamethasone—rheumatoid arthritis	2.87e-05	0.000382	CcSEcCtD
Leflunomide—Pain—Dexamethasone—rheumatoid arthritis	2.85e-05	0.000379	CcSEcCtD
Leflunomide—Pain—Betamethasone—rheumatoid arthritis	2.85e-05	0.000379	CcSEcCtD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	2.85e-05	0.000727	CbGpPWpGaD
Leflunomide—Nervous system disorder—Prednisone—rheumatoid arthritis	2.84e-05	0.000378	CcSEcCtD
Leflunomide—Tachycardia—Prednisone—rheumatoid arthritis	2.83e-05	0.000376	CcSEcCtD
Leflunomide—Skin disorder—Prednisone—rheumatoid arthritis	2.82e-05	0.000374	CcSEcCtD
Leflunomide—DHODH—Metabolism—MTHFR—rheumatoid arthritis	2.81e-05	0.000718	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IRAK1—rheumatoid arthritis	2.81e-05	0.000717	CbGpPWpGaD
Leflunomide—Hyperhidrosis—Prednisone—rheumatoid arthritis	2.8e-05	0.000373	CcSEcCtD
Leflunomide—Vision blurred—Methotrexate—rheumatoid arthritis	2.8e-05	0.000372	CcSEcCtD
Leflunomide—Asthenia—Hydrocortisone—rheumatoid arthritis	2.8e-05	0.000372	CcSEcCtD
Leflunomide—Vomiting—Cyclosporine—rheumatoid arthritis	2.79e-05	0.000371	CcSEcCtD
Leflunomide—Rash—Cyclosporine—rheumatoid arthritis	2.76e-05	0.000368	CcSEcCtD
Leflunomide—Anorexia—Prednisone—rheumatoid arthritis	2.76e-05	0.000367	CcSEcCtD
Leflunomide—Dermatitis—Cyclosporine—rheumatoid arthritis	2.76e-05	0.000367	CcSEcCtD
Leflunomide—Pruritus—Hydrocortisone—rheumatoid arthritis	2.76e-05	0.000367	CcSEcCtD
Leflunomide—Ill-defined disorder—Methotrexate—rheumatoid arthritis	2.75e-05	0.000366	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—TYK2—rheumatoid arthritis	2.75e-05	0.000703	CbGpPWpGaD
Leflunomide—Headache—Cyclosporine—rheumatoid arthritis	2.75e-05	0.000365	CcSEcCtD
Leflunomide—Anaemia—Methotrexate—rheumatoid arthritis	2.74e-05	0.000365	CcSEcCtD
Leflunomide—Feeling abnormal—Dexamethasone—rheumatoid arthritis	2.74e-05	0.000365	CcSEcCtD
Leflunomide—Feeling abnormal—Betamethasone—rheumatoid arthritis	2.74e-05	0.000365	CcSEcCtD
Leflunomide—PTK2B—Signaling by VEGF—IL6—rheumatoid arthritis	2.74e-05	0.000701	CbGpPWpGaD
Leflunomide—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	2.72e-05	0.000362	CcSEcCtD
Leflunomide—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	2.72e-05	0.000362	CcSEcCtD
Leflunomide—Hypersensitivity—Triamcinolone—rheumatoid arthritis	2.7e-05	0.000359	CcSEcCtD
Leflunomide—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	2.7e-05	0.000359	CcSEcCtD
Leflunomide—Malaise—Methotrexate—rheumatoid arthritis	2.68e-05	0.000356	CcSEcCtD
Leflunomide—PTK2B—Immune System—IL2RB—rheumatoid arthritis	2.67e-05	0.000683	CbGpPWpGaD
Leflunomide—Vertigo—Methotrexate—rheumatoid arthritis	2.67e-05	0.000355	CcSEcCtD
Leflunomide—Diarrhoea—Hydrocortisone—rheumatoid arthritis	2.67e-05	0.000355	CcSEcCtD
Leflunomide—Leukopenia—Methotrexate—rheumatoid arthritis	2.66e-05	0.000353	CcSEcCtD
Leflunomide—Urticaria—Betamethasone—rheumatoid arthritis	2.64e-05	0.000352	CcSEcCtD
Leflunomide—Urticaria—Dexamethasone—rheumatoid arthritis	2.64e-05	0.000352	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	2.64e-05	0.000351	CcSEcCtD
Leflunomide—CYP1A2—Melatonin metabolism and effects—NFKB1—rheumatoid arthritis	2.64e-05	0.000674	CbGpPWpGaD
Leflunomide—Dizziness—Prednisolone—rheumatoid arthritis	2.64e-05	0.000351	CcSEcCtD
Leflunomide—Asthenia—Triamcinolone—rheumatoid arthritis	2.63e-05	0.00035	CcSEcCtD
Leflunomide—Body temperature increased—Dexamethasone—rheumatoid arthritis	2.63e-05	0.00035	CcSEcCtD
Leflunomide—Abdominal pain—Betamethasone—rheumatoid arthritis	2.63e-05	0.00035	CcSEcCtD
Leflunomide—Abdominal pain—Dexamethasone—rheumatoid arthritis	2.63e-05	0.00035	CcSEcCtD
Leflunomide—Body temperature increased—Betamethasone—rheumatoid arthritis	2.63e-05	0.00035	CcSEcCtD
Leflunomide—Asthenia—Methylprednisolone—rheumatoid arthritis	2.63e-05	0.000349	CcSEcCtD
Leflunomide—Insomnia—Prednisone—rheumatoid arthritis	2.62e-05	0.000349	CcSEcCtD
Leflunomide—Nausea—Cyclosporine—rheumatoid arthritis	2.6e-05	0.000346	CcSEcCtD
Leflunomide—Paraesthesia—Prednisone—rheumatoid arthritis	2.6e-05	0.000346	CcSEcCtD
Leflunomide—Pruritus—Triamcinolone—rheumatoid arthritis	2.6e-05	0.000345	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—PDE2A—rheumatoid arthritis	2.59e-05	0.000662	CbGpPWpGaD
Leflunomide—Cough—Methotrexate—rheumatoid arthritis	2.59e-05	0.000344	CcSEcCtD
Leflunomide—Pruritus—Methylprednisolone—rheumatoid arthritis	2.59e-05	0.000344	CcSEcCtD
Leflunomide—PTK2B—Immune System—C5—rheumatoid arthritis	2.58e-05	0.00066	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CTSK—rheumatoid arthritis	2.58e-05	0.00066	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IFNG—rheumatoid arthritis	2.58e-05	0.000658	CbGpPWpGaD
Leflunomide—Dizziness—Hydrocortisone—rheumatoid arthritis	2.58e-05	0.000343	CcSEcCtD
Leflunomide—ABCG2—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	2.57e-05	0.000657	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—MBL2—rheumatoid arthritis	2.56e-05	0.000654	CbGpPWpGaD
Leflunomide—Dyspepsia—Prednisone—rheumatoid arthritis	2.55e-05	0.000339	CcSEcCtD
Leflunomide—PTK2B—Immune System—NFATC1—rheumatoid arthritis	2.54e-05	0.000649	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IRF5—rheumatoid arthritis	2.54e-05	0.000649	CbGpPWpGaD
Leflunomide—Arthralgia—Methotrexate—rheumatoid arthritis	2.53e-05	0.000336	CcSEcCtD
Leflunomide—Myalgia—Methotrexate—rheumatoid arthritis	2.53e-05	0.000336	CcSEcCtD
Leflunomide—Chest pain—Methotrexate—rheumatoid arthritis	2.53e-05	0.000336	CcSEcCtD
Leflunomide—Decreased appetite—Prednisone—rheumatoid arthritis	2.52e-05	0.000335	CcSEcCtD
Leflunomide—Rash—Prednisolone—rheumatoid arthritis	2.52e-05	0.000334	CcSEcCtD
Leflunomide—Dermatitis—Prednisolone—rheumatoid arthritis	2.51e-05	0.000334	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	2.51e-05	0.000334	CcSEcCtD
Leflunomide—ABCG2—Metabolism—FADS2—rheumatoid arthritis	2.51e-05	0.000641	CbGpPWpGaD
Leflunomide—Diarrhoea—Methylprednisolone—rheumatoid arthritis	2.5e-05	0.000333	CcSEcCtD
Leflunomide—PTK2B—Immune System—REL—rheumatoid arthritis	2.5e-05	0.000639	CbGpPWpGaD
Leflunomide—Fatigue—Prednisone—rheumatoid arthritis	2.5e-05	0.000332	CcSEcCtD
Leflunomide—Headache—Prednisolone—rheumatoid arthritis	2.5e-05	0.000332	CcSEcCtD
Leflunomide—Discomfort—Methotrexate—rheumatoid arthritis	2.5e-05	0.000332	CcSEcCtD
Leflunomide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	2.49e-05	0.000637	CbGpPWpGaD
Leflunomide—Constipation—Prednisone—rheumatoid arthritis	2.48e-05	0.00033	CcSEcCtD
Leflunomide—Vomiting—Hydrocortisone—rheumatoid arthritis	2.48e-05	0.000329	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—PLB1—rheumatoid arthritis	2.47e-05	0.000632	CbGpPWpGaD
Leflunomide—Rash—Hydrocortisone—rheumatoid arthritis	2.46e-05	0.000327	CcSEcCtD
Leflunomide—Dermatitis—Hydrocortisone—rheumatoid arthritis	2.45e-05	0.000326	CcSEcCtD
Leflunomide—Headache—Hydrocortisone—rheumatoid arthritis	2.44e-05	0.000325	CcSEcCtD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	2.43e-05	0.000621	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IRF8—rheumatoid arthritis	2.43e-05	0.00062	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ITGAM—rheumatoid arthritis	2.43e-05	0.00062	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CCR6—rheumatoid arthritis	2.43e-05	0.00062	CbGpPWpGaD
Leflunomide—Dizziness—Triamcinolone—rheumatoid arthritis	2.43e-05	0.000323	CcSEcCtD
Leflunomide—Anaphylactic shock—Methotrexate—rheumatoid arthritis	2.42e-05	0.000322	CcSEcCtD
Leflunomide—Dizziness—Methylprednisolone—rheumatoid arthritis	2.42e-05	0.000322	CcSEcCtD
Leflunomide—Infection—Methotrexate—rheumatoid arthritis	2.41e-05	0.00032	CcSEcCtD
Leflunomide—Feeling abnormal—Prednisone—rheumatoid arthritis	2.39e-05	0.000318	CcSEcCtD
Leflunomide—Asthenia—Betamethasone—rheumatoid arthritis	2.39e-05	0.000318	CcSEcCtD
Leflunomide—Asthenia—Dexamethasone—rheumatoid arthritis	2.39e-05	0.000318	CcSEcCtD
Leflunomide—Nervous system disorder—Methotrexate—rheumatoid arthritis	2.38e-05	0.000316	CcSEcCtD
Leflunomide—Thrombocytopenia—Methotrexate—rheumatoid arthritis	2.37e-05	0.000315	CcSEcCtD
Leflunomide—Gastrointestinal pain—Prednisone—rheumatoid arthritis	2.37e-05	0.000315	CcSEcCtD
Leflunomide—Nausea—Prednisolone—rheumatoid arthritis	2.37e-05	0.000315	CcSEcCtD
Leflunomide—PTK2B—Immune System—NCF2—rheumatoid arthritis	2.36e-05	0.000603	CbGpPWpGaD
Leflunomide—Pruritus—Dexamethasone—rheumatoid arthritis	2.36e-05	0.000313	CcSEcCtD
Leflunomide—Pruritus—Betamethasone—rheumatoid arthritis	2.36e-05	0.000313	CcSEcCtD
Leflunomide—Skin disorder—Methotrexate—rheumatoid arthritis	2.35e-05	0.000313	CcSEcCtD
Leflunomide—Hyperhidrosis—Methotrexate—rheumatoid arthritis	2.34e-05	0.000311	CcSEcCtD
Leflunomide—Vomiting—Triamcinolone—rheumatoid arthritis	2.33e-05	0.00031	CcSEcCtD
Leflunomide—Vomiting—Methylprednisolone—rheumatoid arthritis	2.33e-05	0.00031	CcSEcCtD
Leflunomide—PTK2B—Immune System—FCGR2A—rheumatoid arthritis	2.32e-05	0.000592	CbGpPWpGaD
Leflunomide—Nausea—Hydrocortisone—rheumatoid arthritis	2.31e-05	0.000308	CcSEcCtD
Leflunomide—Rash—Triamcinolone—rheumatoid arthritis	2.31e-05	0.000308	CcSEcCtD
Leflunomide—Dermatitis—Triamcinolone—rheumatoid arthritis	2.31e-05	0.000307	CcSEcCtD
Leflunomide—Anorexia—Methotrexate—rheumatoid arthritis	2.31e-05	0.000307	CcSEcCtD
Leflunomide—Rash—Methylprednisolone—rheumatoid arthritis	2.31e-05	0.000307	CcSEcCtD
Leflunomide—Dermatitis—Methylprednisolone—rheumatoid arthritis	2.31e-05	0.000307	CcSEcCtD
Leflunomide—Urticaria—Prednisone—rheumatoid arthritis	2.3e-05	0.000306	CcSEcCtD
Leflunomide—PTK2B—Immune System—TRAF6—rheumatoid arthritis	2.3e-05	0.000588	CbGpPWpGaD
Leflunomide—CYP2C9—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	2.3e-05	0.000588	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL1B—rheumatoid arthritis	2.3e-05	0.000587	CbGpPWpGaD
Leflunomide—Headache—Triamcinolone—rheumatoid arthritis	2.3e-05	0.000306	CcSEcCtD
Leflunomide—Headache—Methylprednisolone—rheumatoid arthritis	2.29e-05	0.000305	CcSEcCtD
Leflunomide—Abdominal pain—Prednisone—rheumatoid arthritis	2.29e-05	0.000305	CcSEcCtD
Leflunomide—Body temperature increased—Prednisone—rheumatoid arthritis	2.29e-05	0.000305	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL2—rheumatoid arthritis	2.29e-05	0.000585	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—RBPJ—rheumatoid arthritis	2.28e-05	0.000583	CbGpPWpGaD
Leflunomide—Diarrhoea—Betamethasone—rheumatoid arthritis	2.28e-05	0.000303	CcSEcCtD
Leflunomide—Diarrhoea—Dexamethasone—rheumatoid arthritis	2.28e-05	0.000303	CcSEcCtD
Leflunomide—PTK2B—Immune System—TNFAIP3—rheumatoid arthritis	2.27e-05	0.000581	CbGpPWpGaD
Leflunomide—Hypotension—Methotrexate—rheumatoid arthritis	2.26e-05	0.000301	CcSEcCtD
Leflunomide—DHODH—Metabolism—POMC—rheumatoid arthritis	2.25e-05	0.000574	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—BLK—rheumatoid arthritis	2.25e-05	0.000574	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PTPN2—rheumatoid arthritis	2.22e-05	0.000567	CbGpPWpGaD
Leflunomide—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	2.21e-05	0.000294	CcSEcCtD
Leflunomide—Dizziness—Betamethasone—rheumatoid arthritis	2.2e-05	0.000293	CcSEcCtD
Leflunomide—Dizziness—Dexamethasone—rheumatoid arthritis	2.2e-05	0.000293	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—rheumatoid arthritis	2.19e-05	0.00056	CbGpPWpGaD
Leflunomide—Insomnia—Methotrexate—rheumatoid arthritis	2.19e-05	0.000291	CcSEcCtD
Leflunomide—Nausea—Triamcinolone—rheumatoid arthritis	2.18e-05	0.00029	CcSEcCtD
Leflunomide—Paraesthesia—Methotrexate—rheumatoid arthritis	2.18e-05	0.000289	CcSEcCtD
Leflunomide—Nausea—Methylprednisolone—rheumatoid arthritis	2.17e-05	0.000289	CcSEcCtD
Leflunomide—PTK2B—Immune System—SAA1—rheumatoid arthritis	2.17e-05	0.000555	CbGpPWpGaD
Leflunomide—Dyspnoea—Methotrexate—rheumatoid arthritis	2.16e-05	0.000287	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—NFKB1—rheumatoid arthritis	2.14e-05	0.000548	CbGpPWpGaD
Leflunomide—Hypersensitivity—Prednisone—rheumatoid arthritis	2.14e-05	0.000284	CcSEcCtD
Leflunomide—Dyspepsia—Methotrexate—rheumatoid arthritis	2.13e-05	0.000284	CcSEcCtD
Leflunomide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	2.13e-05	0.000544	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CTSD—rheumatoid arthritis	2.13e-05	0.000543	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—NCF1—rheumatoid arthritis	2.13e-05	0.000543	CbGpPWpGaD
Leflunomide—Vomiting—Betamethasone—rheumatoid arthritis	2.12e-05	0.000281	CcSEcCtD
Leflunomide—Vomiting—Dexamethasone—rheumatoid arthritis	2.12e-05	0.000281	CcSEcCtD
Leflunomide—Decreased appetite—Methotrexate—rheumatoid arthritis	2.11e-05	0.00028	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—rheumatoid arthritis	2.1e-05	0.000537	CbGpPWpGaD
Leflunomide—Rash—Dexamethasone—rheumatoid arthritis	2.1e-05	0.000279	CcSEcCtD
Leflunomide—Rash—Betamethasone—rheumatoid arthritis	2.1e-05	0.000279	CcSEcCtD
Leflunomide—Dermatitis—Dexamethasone—rheumatoid arthritis	2.1e-05	0.000279	CcSEcCtD
Leflunomide—Dermatitis—Betamethasone—rheumatoid arthritis	2.1e-05	0.000279	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	2.09e-05	0.000278	CcSEcCtD
Leflunomide—Fatigue—Methotrexate—rheumatoid arthritis	2.09e-05	0.000278	CcSEcCtD
Leflunomide—Headache—Dexamethasone—rheumatoid arthritis	2.09e-05	0.000277	CcSEcCtD
Leflunomide—Headache—Betamethasone—rheumatoid arthritis	2.09e-05	0.000277	CcSEcCtD
Leflunomide—Asthenia—Prednisone—rheumatoid arthritis	2.08e-05	0.000277	CcSEcCtD
Leflunomide—Pain—Methotrexate—rheumatoid arthritis	2.07e-05	0.000276	CcSEcCtD
Leflunomide—Pruritus—Prednisone—rheumatoid arthritis	2.05e-05	0.000273	CcSEcCtD
Leflunomide—DHODH—Metabolism—ALB—rheumatoid arthritis	2.05e-05	0.000524	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD28—rheumatoid arthritis	2.05e-05	0.000523	CbGpPWpGaD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	2.02e-05	0.000516	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CXCL13—rheumatoid arthritis	2.02e-05	0.000515	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PTPRC—rheumatoid arthritis	2.01e-05	0.000513	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1RN—rheumatoid arthritis	2e-05	0.000511	CbGpPWpGaD
Leflunomide—Feeling abnormal—Methotrexate—rheumatoid arthritis	2e-05	0.000265	CcSEcCtD
Leflunomide—Diarrhoea—Prednisone—rheumatoid arthritis	1.98e-05	0.000264	CcSEcCtD
Leflunomide—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	1.98e-05	0.000263	CcSEcCtD
Leflunomide—Nausea—Dexamethasone—rheumatoid arthritis	1.98e-05	0.000263	CcSEcCtD
Leflunomide—Nausea—Betamethasone—rheumatoid arthritis	1.98e-05	0.000263	CcSEcCtD
Leflunomide—CYP1A2—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	1.97e-05	0.000502	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	1.97e-05	0.000502	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—NOS3—rheumatoid arthritis	1.96e-05	0.000501	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—rheumatoid arthritis	1.96e-05	0.0005	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—rheumatoid arthritis	1.95e-05	0.000498	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-DPB1—rheumatoid arthritis	1.94e-05	0.000496	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—UBE2D1—rheumatoid arthritis	1.93e-05	0.000492	CbGpPWpGaD
Leflunomide—Urticaria—Methotrexate—rheumatoid arthritis	1.92e-05	0.000256	CcSEcCtD
Leflunomide—Dizziness—Prednisone—rheumatoid arthritis	1.92e-05	0.000255	CcSEcCtD
Leflunomide—Body temperature increased—Methotrexate—rheumatoid arthritis	1.92e-05	0.000255	CcSEcCtD
Leflunomide—Abdominal pain—Methotrexate—rheumatoid arthritis	1.92e-05	0.000255	CcSEcCtD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	1.9e-05	0.000485	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD40—rheumatoid arthritis	1.87e-05	0.000477	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ADRBK1—rheumatoid arthritis	1.87e-05	0.000477	CbGpPWpGaD
Leflunomide—Vomiting—Prednisone—rheumatoid arthritis	1.84e-05	0.000245	CcSEcCtD
Leflunomide—PTK2B—Immune System—HMGB1—rheumatoid arthritis	1.84e-05	0.00047	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CTLA4—rheumatoid arthritis	1.84e-05	0.00047	CbGpPWpGaD
Leflunomide—Rash—Prednisone—rheumatoid arthritis	1.83e-05	0.000243	CcSEcCtD
Leflunomide—Dermatitis—Prednisone—rheumatoid arthritis	1.83e-05	0.000243	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—rheumatoid arthritis	1.82e-05	0.000466	CbGpPWpGaD
Leflunomide—Headache—Prednisone—rheumatoid arthritis	1.82e-05	0.000242	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—TLE3—rheumatoid arthritis	1.81e-05	0.000464	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IRAK1—rheumatoid arthritis	1.81e-05	0.000464	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CX3CR1—rheumatoid arthritis	1.8e-05	0.000459	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—PTGS2—rheumatoid arthritis	1.79e-05	0.000458	CbGpPWpGaD
Leflunomide—Hypersensitivity—Methotrexate—rheumatoid arthritis	1.79e-05	0.000237	CcSEcCtD
Leflunomide—PTK2B—Immune System—RASGRP1—rheumatoid arthritis	1.76e-05	0.00045	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—SYK—rheumatoid arthritis	1.76e-05	0.000449	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD79A—rheumatoid arthritis	1.76e-05	0.000449	CbGpPWpGaD
Leflunomide—Asthenia—Methotrexate—rheumatoid arthritis	1.74e-05	0.000231	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—IL2RB—rheumatoid arthritis	1.73e-05	0.000442	CbGpPWpGaD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	1.73e-05	0.000441	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PRKCQ—rheumatoid arthritis	1.72e-05	0.00044	CbGpPWpGaD
Leflunomide—Nausea—Prednisone—rheumatoid arthritis	1.72e-05	0.000229	CcSEcCtD
Leflunomide—Pruritus—Methotrexate—rheumatoid arthritis	1.71e-05	0.000228	CcSEcCtD
Leflunomide—PTK2B—Immune System—STAT1—rheumatoid arthritis	1.69e-05	0.000432	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	1.68e-05	0.000428	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	1.68e-05	0.000428	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PLD4—rheumatoid arthritis	1.67e-05	0.000428	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—C5—rheumatoid arthritis	1.67e-05	0.000427	CbGpPWpGaD
Leflunomide—Diarrhoea—Methotrexate—rheumatoid arthritis	1.66e-05	0.00022	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—rheumatoid arthritis	1.66e-05	0.000423	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NFATC1—rheumatoid arthritis	1.64e-05	0.00042	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—VCAM1—rheumatoid arthritis	1.62e-05	0.000415	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	1.62e-05	0.000414	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-DQA1—rheumatoid arthritis	1.62e-05	0.000414	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ACAN—rheumatoid arthritis	1.62e-05	0.000413	CbGpPWpGaD
Leflunomide—Dizziness—Methotrexate—rheumatoid arthritis	1.6e-05	0.000213	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—CCR6—rheumatoid arthritis	1.57e-05	0.000401	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	1.56e-05	0.000398	CbGpPWpGaD
Leflunomide—Vomiting—Methotrexate—rheumatoid arthritis	1.54e-05	0.000205	CcSEcCtD
Leflunomide—Rash—Methotrexate—rheumatoid arthritis	1.53e-05	0.000203	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—NCF2—rheumatoid arthritis	1.53e-05	0.00039	CbGpPWpGaD
Leflunomide—Dermatitis—Methotrexate—rheumatoid arthritis	1.53e-05	0.000203	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—rheumatoid arthritis	1.52e-05	0.000388	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—SLC25A12—rheumatoid arthritis	1.52e-05	0.000388	CbGpPWpGaD
Leflunomide—Headache—Methotrexate—rheumatoid arthritis	1.52e-05	0.000202	CcSEcCtD
Leflunomide—PTK2B—Immune System—HLA-DQB1—rheumatoid arthritis	1.52e-05	0.000387	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TRAF6—rheumatoid arthritis	1.49e-05	0.00038	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SH2B3—rheumatoid arthritis	1.49e-05	0.00038	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GZMB—rheumatoid arthritis	1.48e-05	0.000378	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GC—rheumatoid arthritis	1.48e-05	0.000378	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PTGES—rheumatoid arthritis	1.48e-05	0.000378	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PTK2—rheumatoid arthritis	1.47e-05	0.000374	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1A—rheumatoid arthritis	1.44e-05	0.000368	CbGpPWpGaD
Leflunomide—Nausea—Methotrexate—rheumatoid arthritis	1.44e-05	0.000191	CcSEcCtD
Leflunomide—PTK2B—Immune System—IL18—rheumatoid arthritis	1.44e-05	0.000367	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CXCL2—rheumatoid arthritis	1.44e-05	0.000367	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCL3—rheumatoid arthritis	1.44e-05	0.000367	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	1.43e-05	0.000366	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	1.43e-05	0.000366	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD40LG—rheumatoid arthritis	1.43e-05	0.000366	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—rheumatoid arthritis	1.42e-05	0.000363	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—rheumatoid arthritis	1.42e-05	0.000363	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CSF2—rheumatoid arthritis	1.42e-05	0.000362	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD8A—rheumatoid arthritis	1.42e-05	0.000362	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SAA1—rheumatoid arthritis	1.4e-05	0.000359	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—AGER—rheumatoid arthritis	1.38e-05	0.000353	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NCF1—rheumatoid arthritis	1.38e-05	0.000351	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PLB1—rheumatoid arthritis	1.37e-05	0.000351	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	1.37e-05	0.000349	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-B—rheumatoid arthritis	1.36e-05	0.000348	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL6—rheumatoid arthritis	1.35e-05	0.000344	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	1.33e-05	0.00034	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CD28—rheumatoid arthritis	1.32e-05	0.000338	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL2RA—rheumatoid arthritis	1.28e-05	0.000326	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—FADS2—rheumatoid arthritis	1.27e-05	0.000324	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—C3—rheumatoid arthritis	1.27e-05	0.000323	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-A—rheumatoid arthritis	1.26e-05	0.000322	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—UBE2D1—rheumatoid arthritis	1.25e-05	0.000318	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—BDKRB2—rheumatoid arthritis	1.22e-05	0.000312	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CXCL12—rheumatoid arthritis	1.22e-05	0.000312	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADRBK1—rheumatoid arthritis	1.21e-05	0.000308	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—MED1—rheumatoid arthritis	1.21e-05	0.000308	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CRP—rheumatoid arthritis	1.2e-05	0.000307	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	1.17e-05	0.000298	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—TLR4—rheumatoid arthritis	1.15e-05	0.000295	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-DRB1—rheumatoid arthritis	1.15e-05	0.000294	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—RASGRP1—rheumatoid arthritis	1.14e-05	0.000291	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SYK—rheumatoid arthritis	1.14e-05	0.00029	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—B3GNT2—rheumatoid arthritis	1.12e-05	0.000286	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ACP5—rheumatoid arthritis	1.12e-05	0.000286	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PRKCQ—rheumatoid arthritis	1.11e-05	0.000285	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6ST—rheumatoid arthritis	1.11e-05	0.000283	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ICAM1—rheumatoid arthritis	1.11e-05	0.000283	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—STAT1—rheumatoid arthritis	1.09e-05	0.00028	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—FADS2—rheumatoid arthritis	1.08e-05	0.000277	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CXCL10—rheumatoid arthritis	1.08e-05	0.000276	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—POMC—rheumatoid arthritis	1.07e-05	0.000274	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD80—rheumatoid arthritis	1.06e-05	0.000272	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	1.05e-05	0.000269	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—BGN—rheumatoid arthritis	1.01e-05	0.000258	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6R—rheumatoid arthritis	9.87e-06	0.000252	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MMP3—rheumatoid arthritis	9.84e-06	0.000251	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PTK2—rheumatoid arthritis	9.47e-06	0.000242	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCL5—rheumatoid arthritis	9.29e-06	0.000237	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALOX5—rheumatoid arthritis	9.29e-06	0.000237	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—POMC—rheumatoid arthritis	9.18e-06	0.000234	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CSF2—rheumatoid arthritis	9.15e-06	0.000234	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	9e-06	0.00023	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—TYK2—rheumatoid arthritis	8.99e-06	0.00023	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SPP1—rheumatoid arthritis	8.6e-06	0.00022	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PLD4—rheumatoid arthritis	8.45e-06	0.000216	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IFNG—rheumatoid arthritis	8.42e-06	0.000215	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCR5—rheumatoid arthritis	8.37e-06	0.000214	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL2RA—rheumatoid arthritis	8.25e-06	0.000211	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—C3—rheumatoid arthritis	8.18e-06	0.000209	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ACAN—rheumatoid arthritis	8.17e-06	0.000209	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD4—rheumatoid arthritis	8.13e-06	0.000208	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SLC25A12—rheumatoid arthritis	7.68e-06	0.000196	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—LEP—rheumatoid arthritis	7.61e-06	0.000194	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ENO1—rheumatoid arthritis	7.57e-06	0.000193	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1B—rheumatoid arthritis	7.51e-06	0.000192	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL2—rheumatoid arthritis	7.48e-06	0.000191	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PTGES—rheumatoid arthritis	7.47e-06	0.000191	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GC—rheumatoid arthritis	7.47e-06	0.000191	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PLD4—rheumatoid arthritis	7.23e-06	0.000185	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—FN1—rheumatoid arthritis	7.18e-06	0.000183	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6ST—rheumatoid arthritis	7.15e-06	0.000183	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	7.08e-06	0.000181	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—NFKB1—rheumatoid arthritis	7e-06	0.000179	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ACAN—rheumatoid arthritis	6.98e-06	0.000178	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PLB1—rheumatoid arthritis	6.94e-06	0.000177	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—MAPK8—rheumatoid arthritis	6.88e-06	0.000176	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CD80—rheumatoid arthritis	6.88e-06	0.000176	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SLC25A12—rheumatoid arthritis	6.56e-06	0.000168	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—POMC—rheumatoid arthritis	6.54e-06	0.000167	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCL2—rheumatoid arthritis	6.4e-06	0.000163	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PTGES—rheumatoid arthritis	6.38e-06	0.000163	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GC—rheumatoid arthritis	6.38e-06	0.000163	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6R—rheumatoid arthritis	6.38e-06	0.000163	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—MED1—rheumatoid arthritis	6.09e-06	0.000156	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PLB1—rheumatoid arthritis	5.93e-06	0.000152	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TYK2—rheumatoid arthritis	5.81e-06	0.000148	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NOS3—rheumatoid arthritis	5.7e-06	0.000146	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ACP5—rheumatoid arthritis	5.66e-06	0.000145	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—B3GNT2—rheumatoid arthritis	5.66e-06	0.000145	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CAT—rheumatoid arthritis	5.45e-06	0.000139	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—MED1—rheumatoid arthritis	5.2e-06	0.000133	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—BGN—rheumatoid arthritis	5.1e-06	0.00013	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CXCL8—rheumatoid arthritis	5.06e-06	0.000129	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—B3GNT2—rheumatoid arthritis	4.84e-06	0.000124	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ACP5—rheumatoid arthritis	4.84e-06	0.000124	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL2—rheumatoid arthritis	4.84e-06	0.000124	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	4.69e-06	0.00012	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MMP9—rheumatoid arthritis	4.58e-06	0.000117	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—MTHFR—rheumatoid arthritis	4.55e-06	0.000116	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NFKB1—rheumatoid arthritis	4.53e-06	0.000116	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MAPK8—rheumatoid arthritis	4.45e-06	0.000114	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6—rheumatoid arthritis	4.4e-06	0.000112	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—BGN—rheumatoid arthritis	4.35e-06	0.000111	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	4.12e-06	0.000105	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—VEGFA—rheumatoid arthritis	4.11e-06	0.000105	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	4.01e-06	0.000102	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	3.82e-06	9.77e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TGFB1—rheumatoid arthritis	3.77e-06	9.63e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	3.76e-06	9.61e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—POMC—rheumatoid arthritis	3.64e-06	9.29e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.52e-06	9e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALB—rheumatoid arthritis	3.32e-06	8.47e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	3.29e-06	8.4e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	3.27e-06	8.35e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	3.21e-06	8.21e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NOS3—rheumatoid arthritis	3.17e-06	8.1e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TP53—rheumatoid arthritis	3.11e-06	7.93e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PTGS2—rheumatoid arthritis	2.9e-06	7.41e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6—rheumatoid arthritis	2.84e-06	7.26e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.81e-06	7.18e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CAT—rheumatoid arthritis	2.75e-06	7.03e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CAT—rheumatoid arthritis	2.35e-06	6.01e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	2.3e-06	5.87e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	1.96e-06	5.01e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—POMC—rheumatoid arthritis	1.84e-06	4.69e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALB—rheumatoid arthritis	1.67e-06	4.28e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	1.6e-06	4.09e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—POMC—rheumatoid arthritis	1.57e-06	4.01e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	1.47e-06	3.74e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALB—rheumatoid arthritis	1.43e-06	3.66e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	1.37e-06	3.5e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	1.25e-06	3.2e-05	CbGpPWpGaD
